TRENTON – The Senate Health, Human Services, and Senior Citizens Committee advanced legislation sponsored by Senator Joe Vitale that would update New Jersey’s immunization laws, ensure consistency across state agencies, and maintain strong vaccine coverage rooted in evidence-based medical guidance.

The bill, S-4894/4726, updates statutory and regulatory references so that New Jersey’s immunization standards are anchored in recommendations issued by the Department of Health. The Department will serve as the state’s primary recommender while considering guidance from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention, as well as recommendations from leading medical organizations including the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, and the American College of Physicians when developing and updating immunization guidance. All state agencies would be required to align their rules and regulations to reflect these Department of Health recommendations.

“New Jersey families and health care providers rely on consistent, evidence-based vaccine guidance,” said Senator Vitale (D-Middlesex). “This legislation ensures our standards remain rooted in medical expertise, even as federal policy becomes less predictable. Recent actions, including the federal move to weaken longstanding Hepatitis B vaccine guidance, show how quickly national recommendations can shift without clear evidence or clinical consensus. New Jersey should not be dependent on abrupt changes that could undermine confidence in immunizations. By empowering the Department of Health to consider the full spectrum of expert recommendations, we are building a more resilient and dependable vaccine policy for our State.”

The legislation will also require health insurers and the State Medicaid Program to cover immunizations with no cost-sharing when the New Jersey Department of Health recommends those immunizations. The Department, in making these determinations, must consider guidance from ACIP and the major medical organizations listed in the bill, ensuring that coverage decisions reflect the best available clinical expertise.

States including California, Colorado, Maine, Maryland, and Washington, D.C., have already moved toward independent or supplemental vaccine guidance. More than twenty states now rely on nonfederal entities for some portion of their immunization recommendations.